Abstract
BackgroundThe quantification of PD-L1 (programmed cell death ligand 1) has been used to predict patient’s survival, to characterize the tumor immune microenvironment, and to predict response to immune checkpoint therapies....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have